News Medical on MSN
Study reveals previously unknown role for viral protein integrase in HIV's life cycle
The tiny shell protecting the HIV virus resembles a slightly rounded ice cream cone, but there is nothing sweet about it.
Researchers revealed that HIV integrase forms structural filaments within the viral capsid, enabling viral infectivity. The ...
Since the HIV epidemic began, the diagnosis of HIV has evolved from a death sentence to a chronic, but manageable condition by starting and staying on treatment. HIV treatment can help people live ...
Just over a year ago, the European Union and the US Food and Drug Administration approved a new anti-retroviral drug to treat human immunodeficiency virus (HIV) infections. Lenacapavir is the first ...
We might be a step closer to curing HIV, as researchers have developed a way to knock out a version of the virus lurking in the body. Using something called an HIV-like particle (HLP)—which are dead ...
If you’re a drug developer, HIV is nothing but a thief. All the virus wants to do is break inside a healthy cell, steal its genetic machinery, and start profiting from the intrusion. To stop a thief, ...
NAIROBI, Feb. 18 (Xinhua) -- Kenya's Ministry of Health has received an initial consignment of 21,000 starter doses of Lenacapavir, a twice-yearly injectable drug for HIV prevention.
Smuggling its genome into the nucleus is essential for HIV to infect its host, but entering the cell’s control center is no easy feat. Molecules must pass through tightly-regulated nuclear pores on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results